Nine Months Ended

September 30,

2015

2014

Supplemental disclosures of Cash Flow Information:

Cash paid for income taxes, net

$

140

$

615

Cash paid for interest

27,736

4,609

Supplemental disclosures of Non-cash Investing and Financing Activities:

Conversion of 8.00% Convertible notes

60,172

-

Issuance of 1,682,086 shares to Zogenix for Zohydro acquisition

11,926

-

Acquisition of TREXIMET® - warrants issued to Pozen

-

2,359

Acquisition of license - contract payable

-

1,950